| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |